SuperworthDavita EPS DVA
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Jun 30, 2026
- $12.22
- Latest quarter, Q2 FY26
- $4.02
- +56% on a year earlier
- Fiscal year 2025
- $9.91
- −8% on the year before
Davita's earnings per share was $12.22 over the twelve months to Jun 30, 2026, up 20% on a year earlier.
In its latest quarter, Q2 FY26, it was $4.02, up 56% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 10% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $9.91 | −8% |
| FY2024 | $10.74 | +45% |
| FY2023 | $7.40 | +28% |
| FY2022 | $5.78 | −35% |
| FY2021 | $8.88 | +41% |
| FY2020 | $6.29 | +17% |
| FY2019 | $5.37 | +580% |
| FY2018 | $0.79 | −77% |
| FY2017 | $3.46 | −19% |
| FY2016 | $4.29 | +249% |
| FY2015 | $1.23 | −63% |
| FY2014 | $3.34 | +13% |
| FY2013 | $2.95 | +8% |
| FY2012 | $2.73 | +10% |
| FY2011 | $2.48 | +26% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $4.02 | +56% | $12.22 | |
| Q1 FY26 | $2.87 | +44% | $10.78 | |
| Q4 FY25 | $3.29 | +6% | $9.91 | |
| Q3 FY25 | $2.04 | −18% | $9.71 | |
| Q2 FY25 | $2.58 | +3% | $10.17 | |
| Q1 FY25 | $2.00 | −25% | $10.09 | |
| Q4 FY24 | $3.09 | +91% | $10.74 | |
| Q3 FY24 | $2.50 | −5% | $9.27 | |
| Q2 FY24 | $2.50 | +31% | $9.39 | |
| Q1 FY24 | $2.65 | +112% | $8.80 | |
| Q4 FY23 | $1.62 | +119% | $7.40 | |
| Q3 FY23 | $2.62 | +132% | $6.52 |
Against its peers
Companies in Medical - Care Facilities nearest Davita's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| DVADavita | $12.22 | +20% a year |
| BTSGBrightSpring Health Services | $1.65 | +432% a year |
| EHCEncompass Health | $6.14 | +20% a year |
| UHSUniversal Health Services | $24.55 | +29% a year |
| ENSGEnsign | $6.38 | +16% a year |
| PACSPACS | $1.75 | +113% a year |
| CHEChemed | $19.92 | +2% a year |
| THCTenet Healthcare | $25.93 | +66% a year |
| SHCSotera Health | $0.57 | +613% a year |
| CONConcentra Group Holdings Parent | $1.54 | +29% a year |
| LFSTLifeStance Health | $0.13 | |
| Peer median | $3.94 |
Where Davita ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Davita
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.